Clinical Characteristics and Predisposing Factors in Candida auris Infection: A Retrospective Analysis

Technical Summary: Clinical Characteristics and Predisposing Factors in Candida auris Infection

Problem Statement
Candida auris has emerged as a formidable global nosocomial pathogen, posing significant challenges due to its multidrug resistance, diagnostic difficulties (often misidentified by conventional phenotypic systems), and association with high mortality in immunocompromised populations. While the pathogen has been identified in multiple Chinese provinces, comprehensive clinical characterization of C. auris infections specifically within Jiangxi Province remains elusive. There is a critical need to understand the local clinical manifestations, predisposing factors, co-infection profiles, and patient outcomes to inform diagnostic and therapeutic protocols.

Methodology
This study employed a retrospective analysis of medical records from a tertiary hospital in Jiangxi Province, covering the period from May 2022 to April 2025.

• Cohort: Eight patients meeting strict inclusion criteria were enrolled: age ≥18, confirmed C. auris infection via microbial culture and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS), presence of clinical infectious symptoms, and complete clinical documentation.
• Exclusion: Patients with missing data, those who died or left against medical advice within 24 hours of admission, those with recurrent infections lacking prior susceptibility records, and asymptomatic carriers were excluded.
• Data Collection: The analysis encompassed demographic data, underlying comorbidities, history of invasive procedures, microbiological results (including co-pathogens), and antimicrobial/antifungal usage records.
• Identification: Isolates were cultured on Sabouraud Dextrose Agar at 37–42°C (screening for thermotolerance) and definitively identified using MALDI-TOF MS in a Biosafety Level 2 (BSL-2) laboratory.
• Statistical Approach: Quantitative data were presented as mean ± standard deviation. Descriptive statistics were used to compare the non-survival group against the survival group; no formal statistical hypothesis testing was conducted.

Key Results

• Patient Demographics and Risk Factors: All eight patients were immunocompromised, had undergone invasive procedures, and were hospitalized in the Intensive Care Unit (ICU). The median age was 70 years. All patients had indwelling devices (central venous catheters, nasogastric tubes, urinary catheters), and seven required mechanical ventilation. The mean hospitalization duration was 263 days.
• Clinical Outcomes: Three patients (37.5%) died, while five recovered. The deceased group exhibited significantly worse laboratory indicators, including elevated white blood cell counts, neutrophil percentages, C-reactive protein (CRP), and procalcitonin levels, alongside decreased lymphocyte counts and renal impairment.
• Microbiological Profile:
  • Co-infections: Gram-negative bacilli were the predominant co-infecting pathogens. Five patients had a history of prior fungal infections (including C. albicans, C. parapsilosis, C. glabrata, and Trichosporon asahii).
  • Antibiotic Exposure: All eight patients received empirical broad-spectrum antibiotics prior to C. auris detection. Gram-negative antimicrobial strategies accounted for 61.5% of the total antibiotic burden. Notably, five patients received empirical glycopeptide or oxazolidinone therapy against gram-positive organisms despite a lack of culture-documented gram-positive infection.
• Antifungal Therapy and Persistence:
  • Seven patients received empirical antifungal therapy prior to the index C. auris isolation.
  • Targeted antifungal therapy failed to achieve microbiological eradication in five patients, who remained culture-positive with serial surveillance cultures.
  • Treatment regimens varied widely, including caspofungin, micafungin, fluconazole, voriconazole, and amphotericin B. One patient received a 102-day uninterrupted course of fluconazole.
  • Despite antifungal intervention, most patients remained culture-positive, highlighting the difficulty in clearing the infection.

Key Contributions
This study provides the first systematic clinical investigation of C. auris infections in Jiangxi Province. It characterizes the specific profile of high-risk patients in this region, emphasizing the convergence of immunosuppression, invasive procedures, and prolonged broad-spectrum antibiotic exposure. The research highlights the prevalence of polymicrobial colonization, particularly with Gram-negative bacilli, and documents the challenge of microbiological clearance even after targeted antifungal therapy.

Significance and Claims
The authors conclude that susceptibility to C. auris is driven by a synergistic interplay of advanced age, immunosuppressive status, and invasive medical procedures. The study posits that these factors, combined with antibiotic use, enhance the adaptive advantages of C. auris by inducing immune exhaustion, disrupting microbial homeostasis, and providing inflammation-mediated nutritional support.

The paper asserts that high-risk patients require close monitoring for C. auris and that individualized clinical management strategies are essential. It underscores the necessity for heightened vigilance in diagnostic and therapeutic protocols, particularly given the pathogen's ability to evade immune recognition and its tendency to persist despite antifungal treatment. The authors acknowledge limitations, including the small sample size (n=8) and the lack of systematic post-discharge follow-up, which restricts the generalizability of the findings and the assessment of long-term relapse rates.